|
Mechanism30S subunit inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date08 Sep 1964 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Chifeng Wanze Pharmaceutical Co Ltd
0 Patents (Medical) associated with Chifeng Wanze Pharmaceutical Co Ltd
100 Deals associated with Chifeng Wanze Pharmaceutical Co Ltd
100 Translational Medicine associated with Chifeng Wanze Pharmaceutical Co Ltd